Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL5867869 | 1.00 | FFAR3 (0.88) | — | |
| Acetic Acid SCHEMBL234816 | 1.00 | FFAR3 (0.88) | — | |
| Acetic Acid SCHEMBL11858088 | 1.00 | FFAR3 (0.88) | — | |
| Acetic Acid SCHEMBL536985 | 1.00 | — | — | |
| Acetic Acid SCHEMBL11857925 | 1.00 | FFAR3 (0.88) | — | |
| Acetic Acid SCHEMBL226015 | 1.00 | — | — | |
| Acetic Acid SCHEMBL52435 | 1.00 | — | — | |
| Acetic Acid SCHEMBL4124082 | 1.00 | — | — | |
| Acetic Acid SCHEMBL51762 | 1.00 | — | — | |
| Acetic Acid SCHEMBL5573359 | 1.00 | FFAR3 (0.88) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 249 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119039133-A | Calcium magnesium acetate prepared from phosphate tailings, and preparation method and application thereof | 郑州大学 | 2024-11-29 | — | — | CN | claimed |
| CN-115093370-A | Crystalline forms of prolyl hydroxylase inhibitors | 菲布罗根有限公司 | 2022-09-23 | — | — | CN | claimed |
| CN-114409596-A | Crystalline forms of prolyl hydroxylase inhibitors | 菲布罗根有限公司 | 2022-04-29 | — | — | CN | claimed |
| CN-113521045-A | Calcium acetate composition and preparation method and application thereof | 北京百美特生物制药有限公司 | 2021-10-22 | — | — | CN | claimed |
| CN-112058272-A | Perovskite type catalyst prepared by sol-gel weak oxidation calcination method and method | 天津大学 | 2020-12-11 | — | — | CN | claimed |
| EP-3429999-A1 | METHOD FOR PREPARING ALKYLAMINES | Commissariat à l'Énergie Atomique et aux Énergies Alternatives (FR) | 2019-01-23 | — | — | EP | claimed |
| CN-101440207-B | Integral skin molded article, method of preparing an integral skin molded article and laminate having integral skin made of polyurethane using the reaction injection molding process | SUMIKA BAYER URETHANE CO LTD | 2012-08-08 | — | — | CN | claimed |
| EP-2292600-A1 | Crystaline forms VI and VII of atorvastatin calcium | Dr. Reddy's Laboratories Ltd. (IN) | 2011-03-09 | — | — | EP | claimed |
| CN-100410236-C | Substituted methylene amide derivatives as protein tyrosine phosphatase modulators | APPLIED RESEARCH SYSTEMS (CH) | 2008-08-13 | — | — | CN | claimed |
| EP-1478344-B1 | MELT EXTRUSION CONSISTING OF SALTS OF ACTIVE INGREDIENTS | ROEHM GMBH (DE) | 2007-05-23 | — | — | EP | claimed |
| EP-1237865-A1 | A FACTORY SCALE PROCESS FOR PRODUCING CRYSTALLINE ATORVASTATIN TRIHYDRATE HEMI CALCIUM SALT | Warner Lambert Research and Development Ireland Limited (IE) | 2002-09-11 | — | — | EP | claimed |
| CN-1070874-C | Process for preparing flexible foams | HENTZMAN ICI CHEMICALS PLC (US) | 2001-09-12 | — | — | CN | claimed |
| WO-2001044181-A1 | A PROCESS FOR PRODUCING CRYSTALLINE ATORVASTATIN CALCIUM | WARNER LAMBERT RESEARCH AND DEVELOPMENT IRELAND LIMITED (IE) | 2001-06-21 | — | — | WO | claimed |
| WO-2001044180-A1 | A FACTORY SCALE PROCESS FOR PRODUCING CRYSTALLINE ATORVASTATIN TRIHYDRATE HEMI CALCIUM SALT | WARNER LAMBERT RESEARCH AND DEVELOPMENT IRELAND LIMITED (IE) | 2001-06-21 | — | — | WO | claimed |
| CN-1251115-A | Process for rigid polyurethane foams | HENTZMAN ICI CHEMICAL PRODUCTS (US) | 2000-04-19 | — | — | CN | claimed |
| CN-1150812-A | Process for preparing flexible foams | ICI PLC (GB) | 1997-05-28 | — | — | CN | claimed |
| US-5430185-A | Process for manufacturing crystalline calcium magnesium acetate | GENERAL ATOMICS INTERNATIONAL SERVICES CORPORATION (US) | 1995-07-04 | — | — | US | claimed |
| EP-0537138-A1 | PROCESS FOR MANUFACTURING CRYSTALLINE CALCIUM MAGNESIUM ACETATE | GENERAL ATOMICS INTERNATIONAL SERVICES CORPORATION (US) | 1993-04-21 | — | — | EP | claimed |
| EP-0537138-A4 | PROCESS FOR MANUFACTURING CRYSTALLINE CALCIUM MAGNESIUM ACETATE. | GEN ATOMICS INTERNAT SERVICES (US) | 1992-05-21 | — | — | EP | claimed |
| WO-1990015112-A1 | PROCESS FOR MANUFACTURING CRYSTALLINE CALCIUM MAGNESIUM ACETATE | CHEVRON RESEARCH AND TECHNOLOGY COMPANY (US) | 1990-12-13 | — | — | WO | claimed |